Elan's High Wire Act Finds a Semi-Safe Net
Elan's and Johnson & Johnson's multi-faceted Alzheimer's disease partnership, announced on July 2, addresses the strategic needs of both parties--but also creates new uncertainties.
Elan's and Johnson & Johnson's multi-faceted Alzheimer's disease partnership, announced on July 2, addresses the strategic needs of both parties--but also creates new uncertainties.